ask="3.20"
ask_size="1200"
average_daily_volume="207660"
bid="2.70"
bid_size="5000"
book_value="0.07"
change="+0.05"
change_from_200_day_moving_average="-0.45"
change_from_50_day_moving_average="-0.19"
change_from_52_week_high="-1.80"
change_From_52_week_low="0.30"
change_in_percent="+1.89%"
close="2.70"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.98"
ebitda="-30.33M"
eps_estimate_current_year="-0.98"
eps_estimate_next_quarter="-0.27"
eps_estimate_next_year="-1.10"
ex_dividend_date="N/A"
float_shares="26690000"
high="2.95"
high_52_weeks="4.50"
last_trade_date="1/11/2017"
last_trade_price="2.70"
last_trade_size="5516"
last_trade_time="4:00pm"
low="2.65"
low_52_weeks="2.40"
market_capitalization="122.40M"
moving_average_200_day="3.15"
moving_average_50_day="2.89"
name="AcelRx Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.80"
open="2.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-14.32%"
percent_change_from_50_day_moving_average="-6.60%"
percent_change_from_52_week_high="-40.00%"
percent_change_from_52_week_low="+12.50%"
previous_close="2.65"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="36.81"
price_per_sales="9.50"
revenue="12.65M"
shares_outstanding="45333000"
short_ratio="17.76"
stock_exchange="NGM"
symbol="ACRX"
volume="738131"
weeks_range_52="2.40 - 4.50"
